Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Prof

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office COP300

Email jamie-miller@ou.edu


Publications & Presentations

<< 5 6 7 8 9 10 11 > >>
    36. Bennett K, Fox A, Miller J, Neely S, Dennis V C, Johnson P. Publication Rates of Pharmacy Residents Involved in a Team-Based Research Program. American Journal of Health-System Pharmacy. 2022; 79 : 2141-2149

    37. Mayes R A, Johnson P N, White B P, Neely S, Chaaban H, Miller J L. Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year Evaluation. Journal of the Pediatric Infectious Diseases Society. 2022; 11 : 349-350

    38. Lim S Y, May C B, Johnson P N, Miller J L. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatric research. 2022

    39. Taher K W, Johnson P N, Miller J L, Neely S, Gupta N. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Frontiers in pediatrics. 2022; 10 : 860921

    40. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022; 79 : 823

<< 5 6 7 8 9 10 11 > >>



Grants

1 2 >>
    1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

    2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

1 2 >>



Awards and Honors

<< 1 2 3 4 5 >>
                                                                                            6. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.  

                                                                                            7. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.  

                                                                                            10. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.  

<< 1 2 3 4 5 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.